We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
This guidance explains how overseas assessments can support our medical device certification and registration processes.
Recently published
This page was published on [date_placeholder].
Recently updated
This page was updated on [date_placeholder]. See page history for details.
The purpose of this guidance is to provide an overview of how specific overseas assessments and approvals can be used by applicants for:
This Guidance is presented as downloadable files because of its wide table format.
Amended to reflect inclusion of UK approved bodies as comparable overseas regulators
Amendments to reflect recent updates to the Determination as part of changes to Regulation 5.3 on 1 July 2024 and the TGA strategy to manage further extension to the EU IVDR transition timelines.
Amendments to reflect the Therapeutic Goods (Medical Devices—Information that Must Accompany Application for Inclusion) Amendment (European Union—Class IIa and Class IIb) Determination 2023.
Corrections, and to reflect end of acceptance of most ISO 13485 certificates for IVDs.
Amendments to clarify the requirements for EUMDR.
Amendments to include Singapore HSA as a comparable overseas regulator.
Amendments to reflect the extended acceptance of ISO13485 certificates as manufacturer evidence for IVD applications in line with EU IVDR (207/746).
Amendments to reflect the repeal of Therapeutic Goods (Medical Devices) Regulations 2002, Regulation 4.1 (requirement for TGA conformity assessment for medical devices containing medicines or materials of animal, microbial, recombinant or human origin, or Class 4 IVDs.
Amendments to reflect changes to application process and requirements for inclusion of Class I non-sterile, non-measuring devices.
Insertion of links to legislative instruments and related notations.
Further clarification on acceptable ISO 13485:2016 certificates for IVD medical devices.
Removal of requirement for attachment of Health Canada Medical licence listing for applications for Class 2 and Class 3 IVD medical devices (to pass preliminary assessment).
Removal of CMDCAS reference for medical devices (that is, non-IVD medical devices).
Clarification of acceptable ISO 13485 certificates for IVD medical devices.
Original publication.
Amended to reflect inclusion of UK approved bodies as comparable overseas regulators
Amendments to reflect recent updates to the Determination as part of changes to Regulation 5.3 on 1 July 2024 and the TGA strategy to manage further extension to the EU IVDR transition timelines.
Amendments to reflect the Therapeutic Goods (Medical Devices—Information that Must Accompany Application for Inclusion) Amendment (European Union—Class IIa and Class IIb) Determination 2023.
Corrections, and to reflect end of acceptance of most ISO 13485 certificates for IVDs.
Amendments to clarify the requirements for EUMDR.
Amendments to include Singapore HSA as a comparable overseas regulator.
Amendments to reflect the extended acceptance of ISO13485 certificates as manufacturer evidence for IVD applications in line with EU IVDR (207/746).
Amendments to reflect the repeal of Therapeutic Goods (Medical Devices) Regulations 2002, Regulation 4.1 (requirement for TGA conformity assessment for medical devices containing medicines or materials of animal, microbial, recombinant or human origin, or Class 4 IVDs.
Amendments to reflect changes to application process and requirements for inclusion of Class I non-sterile, non-measuring devices.
Insertion of links to legislative instruments and related notations.
Further clarification on acceptable ISO 13485:2016 certificates for IVD medical devices.
Removal of requirement for attachment of Health Canada Medical licence listing for applications for Class 2 and Class 3 IVD medical devices (to pass preliminary assessment).
Removal of CMDCAS reference for medical devices (that is, non-IVD medical devices).
Clarification of acceptable ISO 13485 certificates for IVD medical devices.
Original publication.
The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.
© Commonwealth of Australia
